Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Genetic Counseling|September 12, 2023
Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancerCristiane Decat Bergerot, Errol J Philip, Jasnoor Malhotra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell CarcinomaZeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
Clinical Genitourinary Cancer|July 26, 2023
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell CarcinomaNazli Dizman, Ameish Govindarajan, Zeynep B Zengin, et al.
Cancer Investigation|October 14, 2022
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey StudyDaniela V Castro, Zeynep B Zengin, Jasnoor Malhotra, et al.
Prostate Cancer and Prostatic Diseases|February 22, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaborationZeynep B Zengin, Nicholas C Henderson, Joseph J Park, et al.
Clinical Genitourinary Cancer|June 10, 2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer ResearchHedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, et al.
European Urology Oncology|January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell CarcinomaZeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
BJU International|August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapyDaniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
Pageof 3